VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $182,142 | -58.1% | 9,413 | -53.9% | 0.07% | -50.0% |
| Q3 2022 | $435,000 | +9.3% | 20,431 | +20.5% | 0.14% | -51.4% |
| Q1 2022 | $398,000 | -39.3% | 16,961 | -30.9% | 0.28% | +131.4% |
| Q4 2021 | $656,000 | +98.8% | 24,553 | +28.9% | 0.12% | +36.0% |
| Q3 2021 | $330,000 | – | 19,042 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |